Rea Diagnostics

Readiagnostics is a health-tech startup that leverages cutting-edge technology to monitor the risk of preterm birth from the comfort of one's home. Preterm birth, the leading cause of death in children worldwide, is a complex condition to diagnose with 50% of cases being completely unexpected. Readiagnostics addresses this issue by developing a Smart Sanitary Pad that identifies biomarkers in vaginal discharge, indicative of a preterm birth.

The company's primary clients are pregnant women, a demographic that represents 10% of the global population at any given time. The business operates in the healthcare market, specifically within the prenatal care sector. Its business model revolves around the sale of these Smart Sanitary Pads, which not only provide a potentially life-saving service to the user but also valuable data to healthcare providers.

Readiagnostics generates revenue through the direct sale of these pads to consumers and possibly through partnerships with healthcare providers who may use this technology to enhance their prenatal care services. The early alert system provided by the Smart Sanitary Pad allows doctors to take necessary medical action in a timely manner, significantly improving the health outcomes for both mother and baby.

Keywords: Health-tech, Preterm Birth, Home Monitoring, Smart Sanitary Pad, Biomarkers, Prenatal Care, Healthcare Market, Consumer Sales, Healthcare Partnerships, Early Alert System.